At the heart of our new facility are 10 advanced production presses. These presses represent just the beginning, occupying only a quarter of our facility’s capacity. With plans to expand, Vernay is poised for significant growth, aimed to fill the space with up to 45 presses in the near future.
Our facility currently boasts presses equipped with custom molds designed to cater to a wide range of manufacturing requirements. This setup is not just about quantity; it’s about precision and innovation. By specializing in liquid silicone [LSR] molding, we’re targeting markets where the demand for high-quality, reliable components is paramount.
Each of our state-of-the-art production cells can produce 64 parts every 32 seconds, showcasing our commitment to high efficiency and rapid cycle times. The capacity for these cells is delivering over 200 million micro-molded parts per year. This capability is vital for our clients, providing them with the high-quality parts they need at the speed the market demands.
Vernay’s investment in this new Kennesaw facility is a testament to our belief in the importance of cutting-edge technology and custom solutions in manufacturing. Part of this investment is being ISO-13485 and Clean Room Class 8 compliant for the Medical market. We’re not just building components; we’re creating possibilities for new medical devices for the future.
Building on our foundation of innovation, Vernay invites you to challenge us with your toughest projects. Our new Kennesaw facility is primed to take ideas from concept to launch with unmatched precision and efficiency. Let us tackle your most demanding challenges, showcasing how we exceed expectations with custom solutions and high-volume production capabilities.
Stay tuned for more updates as we grow our operations and continue to set new standards in manufacturing excellence.
Vernay Laboratories has been a technology leader in the design, development, and manufacture of customized flow-control components since its founding in 1946. The company also formulates its own compounds to address each specific application.
Vernay’s products play a vital role in millions of medical devices, automobiles, and consumer products. Today, the privately held firm produces more than 1 billion components per year, drawing from a library of more than 33,000 elastomeric materials and compound formulations. It operates six plants around the world, in the U.S., the Netherlands, Italy and China. For more information, visit www.vernay.com.
